{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:47:44Z","timestamp":1793040464161,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"Importance<\/jats:title>Most of the rapid increase in cutaneous melanoma incidence in the US has been localized disease that is treated surgically and is associated with high survival rates. However, little is known about the psychological well-being of survivors in the US.<\/jats:p><\/jats:sec>Objective<\/jats:title>To explore the lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a qualitative and survey-based study that used semistructured interviews and the Fear of Cancer Recurrence Inventory short form (FCRI-SF) survey tool with participants recruited from an academic dermatology practice affiliated with the University of Texas, Austin. Interviews were completed via telephone or in person from August 2021 to September 2022. Each of the 9 items in the FCRI-SF was rated on a 5-point Likert scale, scored from 0 to 4, with a maximum possible score of 36 points. Data analyses were performed from February 2022 to June 2023.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Semistructured interviews were analyzed for themes and subthemes associated with the lived experiences of survivors of cutaneous melanoma. The FCRI-SF scores were tabulated, with scores of 13 or greater identifying potential cases of clinically significant fear of cancer recurrence.<\/jats:p><\/jats:sec>Results<\/jats:title>In all, 51 participants (mean [SD] age, 49.5 [11.7] years; 34 [67%] female and 17 [33%] male) with a history of localized melanoma (stage 0-IIA) completed the interview and survey. Among them, 17 (33%) had survived a diagnosis of stage 0 melanoma, and the remainder, at least 1 invasive melanoma diagnosis (stage I-IIA). Semistructured interviews revealed several themes: (1) emotions surrounding follow-up appointments, (2) intensity of melanoma surveillance, (3) lifestyle changes regarding sun exposure, and (4) thoughts about life and death. Thirty-eight of 51 participants had an FCRI-SF score above the threshold for clinical fear of cancer recurrence.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This qualitative and survey-based study found that despite having an excellent prognosis, some survivors of localized melanoma, even those who had stage 0, have high rates of fear of cancer recurrence and intense survivorship experiences that affect their psychological well-being.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2023.6158","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:01:32Z","timestamp":1707926492000},"page":"495","source":"Crossref","is-referenced-by-count":32,"title":["Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma"],"prefix":"10.1001","volume":"160","author":[{"given":"Ayisha N.","family":"Mahama","sequence":"first","affiliation":[{"name":"Division of Dermatology, Dell Medical School, University of Texas, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney N.","family":"Haller","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Dell Medical School, University of Texas, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Labrada","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Dell Medical School, University of Texas, Austin"},{"name":"Department of Internal Medicine, Dell Medical School, University of Texas, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie I.","family":"Idiong","sequence":"additional","affiliation":[{"name":"Department of Allied Health Sciences, University of Connecticut, Storrs"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex B.","family":"Haynes","sequence":"additional","affiliation":[{"name":"Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas, Austin"},{"name":"Livestrong Cancer Institutes, The University of Texas, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"MaineHealth Institute for Research, Scarborough"},{"name":"Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tsevat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School, University of Texas, Austin"},{"name":"Center for Research to Advance Community Health and Department of Medicine, Long School of Medicine, University of Texas Health Science Center, San Antonio"},{"name":"Department of Population Health, Dell Medical School, The University of Texas, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Pignone","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School, University of Texas, Austin"},{"name":"Livestrong Cancer Institutes, The University of Texas, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewole S.","family":"Adamson","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Dell Medical School, University of Texas, Austin"},{"name":"Department of Internal Medicine, Dell Medical School, University of Texas, Austin"},{"name":"Livestrong Cancer Institutes, The University of Texas, Austin"},{"name":"Deputy Editor, JAMA Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi230074r1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.v73.1","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"doi230074r3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses.","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"doi230074r4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamainternmed.2019.6120","article-title":"Characterizing relative and disease-specific survival in early-stage cancers.","volume":"180","author":"Marcadis","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"7","key":"doi230074r5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamadermatol.2023.1494","article-title":"Risk of mortality after a diagnosis of melanoma in situ.","volume":"159","author":"Patel","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi230074r6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/pon.v22.4","article-title":"Psychosocial aspects of post-treatment follow-up for stage I\/II melanoma: a systematic review of the literature.","volume":"22","author":"Rychetnik","year":"2013","journal-title":"Psychooncology"},{"issue":"12","key":"doi230074r7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1001\/archdermatol.2009.308","article-title":"Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature.","volume":"145","author":"Kasparian","year":"2009","journal-title":"Arch Dermatol"},{"issue":"11","key":"doi230074r8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/pon.v26.11","article-title":"Fear of new or recurrent melanoma after treatment for localised melanoma.","volume":"26","author":"Bell","year":"2017","journal-title":"Psychooncology"},{"issue":"6","key":"doi230074r9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"3","key":"doi230074r10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11764-015-0424-4","article-title":"Screening and comorbidity of clinical levels of fear of cancer recurrence.","volume":"9","author":"Simard","year":"2015","journal-title":"J Cancer Surviv"},{"issue":"3","key":"doi230074r11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00520-008-0444-y","article-title":"Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence.","volume":"17","author":"Simard","year":"2009","journal-title":"Support Care Cancer"},{"issue":"4","key":"doi230074r12","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/hesr.2015.50.issue-4","article-title":"Using grounded theory method to capture and analyze health care experiences.","volume":"50","author":"Foley","year":"2015","journal-title":"Health Serv Res"},{"issue":"2","key":"doi230074r13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0959-8049(94)00333-Z","article-title":"Psychological reactions in patients with malignant melanoma.","volume":"31A","author":"Brandberg","year":"1995","journal-title":"Eur J Cancer"},{"issue":"1","key":"doi230074r14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00000637-199201000-00007","article-title":"Psychosocial aspects of melanoma.","volume":"28","author":"Gibertini","year":"1992","journal-title":"Ann Plast Surg"},{"issue":"2","key":"doi230074r15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0163-8343(94)00098-X","article-title":"Psychological responses to malignant melanoma: an investigation of traumatic stress reactions to life-threatening illness.","volume":"17","author":"Kelly","year":"1995","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"doi230074r16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/CMR.0000000000000348","article-title":"Psychological characteristics of early-stage melanoma patients: a cross-sectional study on 204 patients.","volume":"27","author":"Tesio","year":"2017","journal-title":"Melanoma Res"},{"issue":"2","key":"doi230074r17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11136-015-1088-2","article-title":"Empirical validation of the English version of the Fear of Cancer Recurrence Inventory.","volume":"25","author":"Lebel","year":"2016","journal-title":"Qual Life Res"},{"issue":"12","key":"doi230074r18","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/annonc\/mdq255","article-title":"Quality of life in localised malignant melanoma.","volume":"21","author":"Schlesinger-Raab","year":"2010","journal-title":"Ann Oncol"},{"issue":"15","key":"doi230074r19","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jama.2023.4342","article-title":"Screening for skin cancer: US Preventive Services Task Force recommendation statement.","volume":"329","author":"Mangione","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"doi230074r20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jamadermatol.2023.0706","article-title":"The USPSTF I statement on skin cancer screening: not a disappointment but an opportunity.","volume":"159","author":"Adamson","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"10","key":"doi230074r21","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnci\/djac139","article-title":"Obligate and potential precursors of melanoma.","volume":"114","author":"Elder","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"doi230074r22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cncr.34490","article-title":"Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very-low melanoma mortality.","volume":"129","author":"Eguchi","year":"2023","journal-title":"Cancer"},{"issue":"23","key":"doi230074r23","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1056\/NEJMp1615069","article-title":"Income and cancer overdiagnosis: when too much care is harmful.","volume":"376","author":"Welch","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"doi230074r24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/bjd.12800","article-title":"Socioeconomic status and cutaneous malignant melanoma in Northern Europe.","volume":"170","author":"Idorn","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi230074r25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/1097-0142(19950115)75:2+<637::AID-CNCR2820751404>3.0.CO;2-#","article-title":"Occupation and the risk of malignant melanoma.","volume":"75","author":"Pion","year":"1995","journal-title":"Cancer"},{"issue":"5","key":"doi230074r26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/02841860902913546","article-title":"Occupation and cancer: follow-up of 15 million people in five Nordic countries.","volume":"48","author":"Pukkala","year":"2009","journal-title":"Acta Oncol"},{"issue":"11","key":"doi230074r27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamainternmed.2022.4342","article-title":"Association of UV radiation exposure, diagnostic scrutiny, and melanoma incidence in US counties.","volume":"182","author":"Adamson","year":"2022","journal-title":"JAMA Intern Med"},{"key":"doi230074r2","unstructured":"Cancer Stat Facts. Melanoma of the Skin. Accessed May 15, 2023. https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2815037\/jamadermatology_mahama_2024_oi_230074_1715718017.74858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:04:06Z","timestamp":1715785446000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2815037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.6158","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}